🕵️ Annovis BIO, Inc. ($ANVS)
SEC insider & ownership activity, last 12 months · CIK 1477845 · every row links its SEC filing
Over the last 12 months insiders bought $4.3M with no open-market selling against it. Michael B. Hoffman bought $4.1M (Oct–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $4.3M (15 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Michael B. Hoffman | 14 | $4.1M | 0 | – | May 20, 2026 |
| Maccecchini Maria-Luisa | 1 | $200K | 0 | – | Oct 28, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 5.6% | 13G | Jul 29, 2026 | filing ↗ | |
| Ryan M. Lane | 5.6% | 13G | Jul 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Mark K. White | $15K | Apr 2, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | May 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 28, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 26, 2025 | filing ↗ |
| Other events (8.01) | Oct 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 26, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 10, 2025 | filing ↗ |
| Other events (8.01) | Oct 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 25, 2025 | filing ↗ |